Loading ...
Originally(passive) was ... Designedjbb.1000049 Metronomic Chemotherapy
It is also used treatments , for instancecreatingnanorobots for chemotherapy
ConclusionThese strong population preferences should be consideredwhen designingchemotherapy care
to attack cells in your body , like cancer cells(passive) are designedChemotherapy treatments
to kill fast - growing cancer cells(passive) is designednccn.org ) Chemotherapy
Serious diseasespreventchemotherapy treatments
Genome - wide discovery of lociinfluencingchemotherapy cytotoxicity
to prevent recurrence of the disease , particularly distant recurrence(passive) is designedAdjuvant chemotherapy
differences in software tools / algorithms used by different participating sites ( 2(passive) caused byneoadjuvant chemotherapy
thе body frοm liver destructionresultingfrοm chemotherapy
to kill cancer cells that have spread from a point of origin to other locations in the body(passive) are designedChemotherapy treatments
5-fluorouracil--《Chongqing Medicine》2017年21期 Effect evaluation of 2 % anisodamine cream in preventing chemotherapy phlebitis caused by 5-fluorouracil Liu Dan;Liao(passive) caused bychemotherapy phlebitis
to make the patient more comfortable and may stabilise or even reduce the tumours(passive) is designedPalliative chemotherapy
to stall the cancer or reduce the symptoms(passive) is designedPalliative chemo
to target cells that are abnormally dividing(passive) is designedChemotherapy ( Chemo
Both photothermal therapy ( PTT ) andcan triggergenotoxic chemotherapy
Peripheral NeuropathyCausedoverstep Chemotherapy
for patients with terminal cancer(passive) is designedPalliative chemotherapy
Rarely radiotherapy may affect the lungs ,causingpneumonitis , Chemotherapy
to avoid these problems by administrating chemotherapeutic agents at very low doses ( 1/10th – 1/3rd of the maximum tolerated dose(passive) was designedMetronomic chemotherapy
to destroy cells , especially fast - growing cells , including cancer tumors(passive) are designed specificallyChemotherapy treatments
to shrink the primary tumour(passive) is designedNeoadjuvant chemotherapy
a wound infectionpreventingadjuvant chemotherapy
an attemptto preventrecurrences chemotherapy
Chan , TS , Hsu , CC , Pai , VC , Liao , WY , Huang , SS , Tan , KT , Yen , CJ , Hsu , SC , Chen , WY , Shan , YS , Li , CR , Lee , MT , Jiang , KY , Chu , JM , Lien , GS , Weaver , VM & Tsai , K - C 2016preventsMetronomic chemotherapy
Improvements in detection , anti - estrogen therapies , andhave ledcytotoxic chemotherapy
Combination of chemotherapy and nerve - protecting agentscan preventanemiaCancer chemotherapy
to lower the risk of recurrence of a cancer(passive) is designedAdjuvant chemotherapy
following appropriateto preventcytotoxic chemotherapy
Concurrent gemcitabine+S-1contributesneoadjuvant chemotherapy
reimbursementsinfluencingchemotherapy treatments
chemotherapy drugs(passive) caused bychemotherapy phlebitis
IV afflictionmay resultneoadjuvant chemotherapy
This multimodality treatment approach with debulking surgery andhas resultedintraperitoneal chemotherapy
Most patients who have NSCLC present with advanced or incurable disease , andresultscytotoxic chemotherapy
to : Relieve Symptoms(passive) is designedPalliative chemotherapy
doxorrubicin monthly alternated with carboplatin(passive) composed byadjuvant chemotherapy
5-fluorouracil[J];重庆医学;2017 - 21 2 ZHANG(passive) caused bychemotherapy phlebitis
for use at the maximum tolerated dose ( MTD(passive) is designedCytotoxic chemotherapy
postoperative radiotherapy ( PORT(passive) could have been prevented byadjuvant chemotherapy
anti - emetics Nausea and vomiting(passive) caused byanti - emetics Nausea and vomiting
in more frequent neutropenia , febrile neutropenia , growth factor usage , nausea , vomiting , neuropathy , and alopeciaresultedin more frequent neutropenia , febrile neutropenia , growth factor usage , nausea , vomiting , neuropathy , and alopecia
active hair losscausesactive hair loss
to an increased risk for metabolic syndrome in breast cancer patients and these changes are more profound in pre - menopausal patients [ 14may contributeto an increased risk for metabolic syndrome in breast cancer patients and these changes are more profound in pre - menopausal patients [ 14
a temporary and complete hair losscausesa temporary and complete hair loss
IBP from progressing to multiple myeloma.[16may preventIBP from progressing to multiple myeloma.[16
in complete and lasting resolution of the recurrence and shrinkage of the tumor without visual compromise ( Bresultedin complete and lasting resolution of the recurrence and shrinkage of the tumor without visual compromise ( B
her to have an allergic reaction that left her body riddled with painful blisters inside and out ShareByKatherine Bainbridge15:03causedher to have an allergic reaction that left her body riddled with painful blisters inside and out ShareByKatherine Bainbridge15:03
to minimize her symptoms.[5designedto minimize her symptoms.[5
recurrence and extends survivalpreventsrecurrence and extends survival
nausea , hair loss , vomiting , and mouth soresmay causenausea , hair loss , vomiting , and mouth sores
recurrence of diseasewill preventrecurrence of disease
to prolong survival and ease symptoms , but not cure disease ) or experimental treatmentsdesignedto prolong survival and ease symptoms , but not cure disease ) or experimental treatments
severe toxicity(passive) caused bysevere toxicity
direct toxicitycausesdirect toxicity
to improvements in survival and quality - of - life measures ... but due to cumulative toxicity , guidelines limit the duration of treatment with currently available agentscan leadto improvements in survival and quality - of - life measures ... but due to cumulative toxicity , guidelines limit the duration of treatment with currently available agents
many different side effectscan causemany different side effects
in improved OS and DFS relative to the same chemotherapy administered postoperatively.3 Patients with operable , palpable , biopsy - proven early - stage breast cancerwould resultin improved OS and DFS relative to the same chemotherapy administered postoperatively.3 Patients with operable , palpable , biopsy - proven early - stage breast cancer
to prolong survival and ease symptoms , but not to cure disease - among patients whom physicians had determineddesignedto prolong survival and ease symptoms , but not to cure disease - among patients whom physicians had determined
to longer survival among patients with early breast cancerledto longer survival among patients with early breast cancer
in significantly improved disease - free survival in in patients with esophageal squamous cell cancer ( 18resultedin significantly improved disease - free survival in in patients with esophageal squamous cell cancer ( 18
Survival differences(passive) were influenced bySurvival differences
recurrence from GC [ 10could preventrecurrence from GC [ 10
long - term side effects that do not go awaycauseslong - term side effects that do not go away
severe neutropenia and mucositiscausingsevere neutropenia and mucositis
Facebook Twitter Google Plus LinkedIn Side Effects(passive) Caused byFacebook Twitter Google Plus LinkedIn Side Effects
recurrence ' theoretically speakingwould preventrecurrence ' theoretically speaking
to better chances of survivalcould also contributeto better chances of survival
in a signiWcant survival beneWtresultedin a signiWcant survival beneWt
to better survival outcomescan leadto better survival outcomes
a cancer rash , or a rash associated with cancer treatment ... as these potent medications often affect not only malignant cells , but may alsocausesa cancer rash , or a rash associated with cancer treatment ... as these potent medications often affect not only malignant cells , but may also
intravesical recurrence of superficial bladder cancercould preventintravesical recurrence of superficial bladder cancer
local recurrence rather than distant metastasespreventslocal recurrence rather than distant metastases
in increased risk of radiation neuropathy [ 10could resultin increased risk of radiation neuropathy [ 10
menstrual disruptions and premature menopause , which may in turn impair their quality of life ( QoLmay causemenstrual disruptions and premature menopause , which may in turn impair their quality of life ( QoL
in survival of almost 1 yearresultingin survival of almost 1 year
in a higher survival of patients with osteosarcomaresultedin a higher survival of patients with osteosarcoma
to an increased survival rate in stageledto an increased survival rate in stage
in longer progression - free survivalresultsin longer progression - free survival
cardiac and pulmonary toxicity , due to doxorubicin and bleomycinrespectively Recognition isa third clinically useful construct where the patient ispresented with the actual target item and several dis - tracters and asked to identify the original itemcan causecardiac and pulmonary toxicity , due to doxorubicin and bleomycinrespectively Recognition isa third clinically useful construct where the patient ispresented with the actual target item and several dis - tracters and asked to identify the original item